A bipartisan pair of House lawmakers has filed legislation that would preserve legal sales of many hemp-derived THC products currently on shelves, cutting back a sweeping restriction set to take effect November 12. Reps. Andy Barr (R-KY) and Angie Craig (D-MN) introduced the Lawful Hemp Protection Act on Wednesday, and the bill carries real weight: it reportedly has backing from the White House, and both sponsors are running for U.S. Senate seats this cycle, which tends to sharpen political attention on a bill rather than dilute it.
For retailers and processors watching the November deadline approach, the stakes are operational as much as political. Hemp shops, CBD wholesalers and beverage distributors have spent the past year building compliance systems, inventory categories and point-of-sale configurations around a THC threshold that Congress is now proposing to rewrite again. Multi-state operators managing hemp-adjacent SKUs alongside regulated cannabis lines already juggle separate compliance logs and tax treatments; in states like Minnesota, where hemp-derived beverages and low-dose products moved through licensed retail channels well ahead of federal clarity, businesses running platforms such as Minnesota cannabis POS systems have had to track evolving definitions of "legal hemp" almost in real time. Another redefinition, even a more permissive one, means another round of SKU audits, label reprints and staff retraining.
What the Bill Would Actually Change
The core mechanism here is a redefinition of hemp itself. Instead of the 0.4 milligram total THC per container standard set to kick in this fall, the new bill would allow concentrations up to 1 percent total THC on a dry-weight basis - a meaningfully looser ceiling that would keep a large share of today's hemp-derived products, including many beverages and tinctures, on the legal side of the line. That's the headline change, but it's not the whole story. The bill also draws a hard line against synthetic and semi-synthetic cannabinoids, specifically naming HHC, THC-O-acetate and THCP as prohibited substances, while giving federal health and agriculture officials authority to blacklist other lab-modified analogs down the road.
In practice, though, this is less a free pass and more a trade: broader THC allowances in exchange for a tighter regulatory harness. The legislation would impose federal permitting requirements on manufacturers and wholesalers, mandate certificates of analysis accessible via QR code, require age-21 labeling, and ban packaging that could appeal to minors. It would also establish a three-tier distribution system for hemp beverages - manufacturer, wholesaler, retailer - mirroring the alcohol industry's long-standing tied-house separation, with no entity permitted to hold interests across more than one tier.
Taxes, Enforcement and the Compliance Bill Ahead
New federal taxes would apply across the board: a 5 percent sales tax on most hemp consumables, a 5-cent-per-milligram-of-THC tax on beverages, and an additional 5 percent tax on manufacturers' annual revenue. Revenue would flow into a dedicated trust fund covering oversight, consumer protection work and state cooperation grants, with a slice of beverage tax proceeds earmarked for impaired-driving enforcement through the Highway Trust Fund. States would face pressure to align hemp-impaired driving penalties with existing DUI frameworks or risk losing certain federal funds - a provision that puts hemp retailers on notice that consumer-safety enforcement is coming whether or not this exact bill becomes law.
Why the Fight Isn't Over
Barr has tried this before, and the amendments were blocked from floor consideration by the House Rules Committee - a reminder that White House support and bipartisan authorship don't guarantee passage. Opposition, by Barr's own account, comes from an unusual mix: parts of the alcohol industry protective of shelf space, marijuana operators wary of unregulated hemp competition undercutting their heavily taxed, state-licensed products, and prohibition-minded groups opposed to any THC access outside strict medical channels. For dispensary owners in adult-use and medical markets, the outcome matters beyond hemp shelves; it will shape how much competitive pressure licensed cannabis retail continues to face from lightly regulated hemp substitutes, and whether federal potency and labeling standards eventually converge with the compliance regimes state cannabis programs already enforce.
